Cloroqualone
Jump to navigation
Jump to search
| File:Cloroqualone.png | |
| Gene therapy | |
|---|---|
| Clinical data | |
| Pregnancy category |
|
| Routes of administration | ? |
| Physiological data | |
| Legal status | |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Elimination half-life | ? |
| Excretion | ? |
| Identifiers | |
| |
| CAS Number | |
| PubChem Template:Abbreviation | |
| DrugBank | |
| Chemical and physical data | |
| Formula | C16H12Cl2N2O |
| Molar mass | 319.185 |
| 3D model (JSmol) | |
| |
Cloroqualone is an analogue of methaqualone developed in the 1980s and marketed mainly in France and some other European countries. It has sedative and antitussive properties, and was sold either alone or in combination with other ingredients as a cough medicine. [1] Cloroqualone has weaker sedative properties than methaqualone and was sold for its useful cough-suppressing effects, but was withdrawn from the French market in 1994 because of concerns about its potential for abuse and overdose.
See also
References
Categories:
- Articles with short description
- Pages with broken file links
- Pages using infobox drug with unknown parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Sedatives